[Regulation of natural medicines in Israel and abroad]
- PMID: 11341206
[Regulation of natural medicines in Israel and abroad]
Abstract
Hand-in-hand with the public's growing interest in health care, there has been an increasing demand for natural health products considered both safe and medically effective. But many such products have not been shown to meet efficacy and safety criteria and therefore can not be registered as pharmaceuticals. On the other hand, it is quite clear that some products do have pharmacological activity and are being used for therapeutic or preventive effects. In Israel, the marketing rules for food or dietary supplements prevent their manufacturers from claiming medicinal/healing properties that the product might have, and allow only limited health statements. But great demand for these products has created massive publication attributing medicinal indications for products whose quality, efficacy and safety have neither been examined nor proven according to accepted medical criteria. We review the regulation and supervision of natural health products in Israel and other developed countries and find a broad range of opinions about natural health products. They range from acceptance as conventional drugs reimbursable by health insurance, as in Switzerland and Germany, to their status as dietary supplements requiring no significant authorization or supervision, as in the USA. Analysis of the current situation in Israel and the western world would indicate that some natural health products do possess pharmacological activity and therefore manufacturers should be allowed to make limited claims for specified therapeutic properties. A stricter set of registration regulations are needed for proof of safety, efficacy and quality of these products, but more lenient than those for registering a pharmaceutical product.
Similar articles
-
Regulatory issues concerning the safety, efficacy and quality of herbal remedies.Birth Defects Res B Dev Reprod Toxicol. 2003 Dec;68(6):505-10. doi: 10.1002/bdrb.10053. Birth Defects Res B Dev Reprod Toxicol. 2003. PMID: 14745988
-
The impact of cGMP compliance on consumer confidence in dietary supplement products.Toxicology. 2006 Apr 3;221(1):9-16. doi: 10.1016/j.tox.2006.01.011. Epub 2006 Feb 15. Toxicology. 2006. PMID: 16469425
-
[Regulatory issues of biologically active supplements in Armenia].Vopr Pitan. 2003;72(1):27-9. Vopr Pitan. 2003. PMID: 12664696 Russian.
-
[Special therapeutic guidelines from the viewpoint of BfArM (Federal Institute for Drug and Medical Products)].Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):669-74. Z Arztl Fortbild Qualitatssich. 1997. PMID: 9527466 Review. German.
-
Implementing a "quality by design" approach to assure the safety and integrity of botanical dietary supplements.J Nat Prod. 2012 Sep 28;75(9):1665-73. doi: 10.1021/np300434j. Epub 2012 Aug 31. J Nat Prod. 2012. PMID: 22938174 Review.
Cited by
-
Potential drug interactions with dietary and herbal supplements during hospitalization.Intern Emerg Med. 2017 Apr;12(3):301-310. doi: 10.1007/s11739-016-1548-x. Epub 2016 Oct 5. Intern Emerg Med. 2017. PMID: 27709322
-
Adverse events associated with interactions with dietary and herbal supplements among inpatients.Br J Clin Pharmacol. 2017 Apr;83(4):836-845. doi: 10.1111/bcp.13158. Epub 2016 Nov 25. Br J Clin Pharmacol. 2017. PMID: 27759172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical